D.E. Shaw & Co’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-24,318
| Closed | -$376K | – | 3351 |
|
|
2024
Q1 | $376K | Buy |
24,318
+15,892
| +189% | +$246K | ﹤0.01% | 2517 |
|
|
2023
Q4 | $236K | Buy |
+8,426
| New | +$236K | ﹤0.01% | 2635 |
|
|
2022
Q3 | – | Sell |
-2,157
| Closed | -$148K | – | 4057 |
|
|
2022
Q2 | $148K | Sell |
2,157
-2,625
| -55% | -$180K | ﹤0.01% | 3480 |
|
|
2022
Q1 | $681K | Buy |
4,782
+3,325
| +228% | +$474K | ﹤0.01% | 3067 |
|
|
2021
Q4 | $243K | Buy |
1,457
+648
| +80% | +$108K | ﹤0.01% | 3404 |
|
|
2021
Q3 | $113K | Sell |
809
-1,815
| -69% | -$254K | ﹤0.01% | 3376 |
|
|
2021
Q2 | $1.25M | Buy |
2,624
+18
| +0.7% | +$8.59K | ﹤0.01% | 2368 |
|
|
2021
Q1 | $1.07M | Sell |
2,606
-17,144
| -87% | -$7.06M | ﹤0.01% | 2145 |
|
|
2020
Q4 | $9.68M | Sell |
19,750
-5,147
| -21% | -$2.52M | 0.01% | 987 |
|
|
2020
Q3 | $14.1M | Sell |
24,897
-15,861
| -39% | -$8.98M | 0.01% | 744 |
|
|
2020
Q2 | $3.88M | Buy |
40,758
+16,299
| +67% | +$1.55M | ﹤0.01% | 1292 |
|
|
2020
Q1 | $1.75M | Buy |
24,459
+6,388
| +35% | +$456K | ﹤0.01% | 1579 |
|
|
2019
Q4 | $1.25M | Buy |
18,071
+5,172
| +40% | +$357K | ﹤0.01% | 1818 |
|
|
2019
Q3 | $1.03M | Sell |
12,899
-2,892
| -18% | -$232K | ﹤0.01% | 1843 |
|
|
2019
Q2 | $1.02M | Buy |
15,791
+1,526
| +11% | +$98.3K | ﹤0.01% | 1877 |
|
|
2019
Q1 | $1.96M | Sell |
14,265
-1,132
| -7% | -$156K | ﹤0.01% | 1577 |
|
|
2018
Q4 | $1.39M | Buy |
15,397
+860
| +6% | +$77.8K | ﹤0.01% | 1706 |
|
|
2018
Q3 | $2.21M | Buy |
14,537
+89
| +0.6% | +$13.5K | ﹤0.01% | 1492 |
|
|
2018
Q2 | $2.49M | Sell |
14,448
-567
| -4% | -$97.5K | ﹤0.01% | 1483 |
|
|
2018
Q1 | $2.2M | Sell |
15,015
-4,007
| -21% | -$588K | ﹤0.01% | 1462 |
|
|
2017
Q4 | $3.86M | Sell |
19,022
-8,415
| -31% | -$1.71M | 0.01% | 1191 |
|
|
2017
Q3 | $8.8M | Buy |
27,437
+1,074
| +4% | +$345K | 0.01% | 771 |
|
|
2017
Q2 | $5.96M | Sell |
26,363
-2,552
| -9% | -$577K | 0.01% | 918 |
|
|
2017
Q1 | $6.52M | Buy |
28,915
+1,996
| +7% | +$450K | 0.01% | 855 |
|
|
2016
Q4 | $5.33M | Buy |
26,919
+654
| +2% | +$129K | 0.01% | 954 |
|
|
2016
Q3 | $6.46M | Buy |
26,265
+25,790
| +5,429% | +$6.34M | 0.01% | 841 |
|
|
2016
Q2 | $276K | Buy |
+475
| New | +$276K | ﹤0.01% | 2283 |
|